85 related articles for article (PubMed ID: 3118817)
1. [UFTM therapy in patients with unresectable pancreatic cancer].
Uchida Y; Yamaoka K; Kisu T; Mori H; Muto Y
Gan To Kagaku Ryoho; 1987 Nov; 14(11):3151-4. PubMed ID: 3118817
[TBL] [Abstract][Full Text] [Related]
2. [UFT-therapy and UFTM therapy--comparison of survivals in the patients with Borrmann type 4 gastric cancer treated either with UFTM-chemotherapy or operation].
Suga S; Kimura K; Yokoyama Y
Gan To Kagaku Ryoho; 1984 Mar; 11(3 Pt 2):769-74. PubMed ID: 6424582
[TBL] [Abstract][Full Text] [Related]
3. [Combined UFTM for 140 patients with advanced gastric cancer].
Jin ML
Zhonghua Zhong Liu Za Zhi; 1989 Mar; 11(2):130-2. PubMed ID: 2553364
[TBL] [Abstract][Full Text] [Related]
4. [UFT, UFTM, and UFTM-Dpc treatment of gastric cancer].
Suga S; Kimura K; Iwase H; Ina K; Takada N; Matsuoka S; Matsuura T; Yamada K; Horiuchi T; Hashizume H
Gan No Rinsho; 1985 May; 31(6 Suppl):751-6. PubMed ID: 3928942
[TBL] [Abstract][Full Text] [Related]
5. [A case of unresectable pancreatic cancer that responded to UFT chemotherapy].
Sato Y; Sakai T; Okada T; Sasano Y; Ando T; Haruta J; Kanayama K; Kuwahara Y; Tachino H; Tahara H
Gan No Rinsho; 1990 Sep; 36(11):2073-8. PubMed ID: 2232175
[TBL] [Abstract][Full Text] [Related]
6. [A combined chemotherapy with UFT and mitomycin C in advanced gastric cancer; report of 2 cases].
Nakata K; Shigemitsu M; Joya K; Sato K; Hara S; Hanawa S
Gan To Kagaku Ryoho; 1985 Aug; 12(8):1694-6. PubMed ID: 3927850
[TBL] [Abstract][Full Text] [Related]
7. [Optimal dosage of UFT + MMC combination chemotherapy for advanced colorectal cancer--phase I/II study of combination chemotherapy of MMC with 2-week intervals and intermittent UFT administration--Study Group of UFTM Therapy for Advanced Colorectal Cancer].
Ikeda E; Kodaira S; Teramoto T; Okuda M; Takahashi T; Kato T; Yamamoto Y; Isomoto H
Gan To Kagaku Ryoho; 1996 Sep; 23(10):1291-8. PubMed ID: 8831741
[TBL] [Abstract][Full Text] [Related]
8. [Chemotherapy of Borrmann's type IV diffuse carcinoma of the stomach].
Suga S; Kimura K; Yokoyama Y
Gan To Kagaku Ryoho; 1983 Dec; 10(12):2478-84. PubMed ID: 6418076
[TBL] [Abstract][Full Text] [Related]
9. [Vincristine, adriamycin, mitomycin-C and UFT (VAM-UFT) therapy in progressive or recurrent breast cancer].
Yasutake K; Imamura Y; Yoshimura Y; Oya M; Matsushita K; Hozumi T; Katou J; Okutani T; Irie K
Gan To Kagaku Ryoho; 1989 Jul; 16(7):2373-9. PubMed ID: 2502072
[TBL] [Abstract][Full Text] [Related]
10. [A case of an aged woman with advanced gastric cancer which dramatically responded to combined chemotherapy with UFT and mitomycin C].
Adachi M; Sasaki M
Gan To Kagaku Ryoho; 1986 Sep; 13(9):2856-7. PubMed ID: 3092746
[TBL] [Abstract][Full Text] [Related]
11. [MQF-FT and MQF-UFT in gallbladder and bile duct cancer].
Sakata Y; Fukushi G; Tsushima K; Suzuki H; Kimura T; Kimura M; Tamura Y; Kishibe T; Saitoh S; Itoh T
Gan To Kagaku Ryoho; 1988 Sep; 15(9):2731-5. PubMed ID: 3137889
[TBL] [Abstract][Full Text] [Related]
12. [Clinical effect of combined chemotherapy with UFT, MMC and OK-432 in recurring or advanced cancer of the digestive organs].
Aoki Y; Tabuse Y; Tanimura H; Katsumi M; Asae M; Ichimiya G; Imai T; Ooshima K; Kakihara M; Kashitani M
Gan To Kagaku Ryoho; 1989 Feb; 16(2):225-34. PubMed ID: 2493222
[TBL] [Abstract][Full Text] [Related]
13. Phase II trial of epirubicin, cisplatin, oral uracil and tegafur, and leucovorin in patients with advanced gastric carcinoma.
Jeen YT; Yoon SY; Shin SW; Kim BS; Mok YJ; Kim CS; Hyun JH; Kim JS; Kim YH
Cancer; 2001 Jun; 91(12):2288-93. PubMed ID: 11413517
[TBL] [Abstract][Full Text] [Related]
14. [Effect of UFTM therapy on primary and metastatic colon cancer of human xenotransplanted in nude mice].
Takahashi Y; Ohta T; Mai M
Gan To Kagaku Ryoho; 1988 Sep; 15(9):2815-7. PubMed ID: 3137893
[No Abstract] [Full Text] [Related]
15. [UFT + MMC and UFT + ACNU therapy in advanced gastric cancer].
Sasai T; Kurihara M; Kubo Y; Nakano S; Kamano T; Taguchi S; Fukuyama E; Suwa T; Miyoshi K; Oda K
Gan To Kagaku Ryoho; 1988 Jan; 15(1):141-6. PubMed ID: 3122666
[TBL] [Abstract][Full Text] [Related]
16. Antitumor effect and survival benefit of chemotherapy for unresectable advanced gastric cancer.
Kiyohashi A; Kurihara M; Yoshida S; Ohkubo T; Suga S
Jpn J Clin Oncol; 1993 Feb; 23(1):41-5. PubMed ID: 8459640
[TBL] [Abstract][Full Text] [Related]
17. [Improved quality of life in a patient with Borrmann type 4 gastric cancer treated with combination chemotherapy].
Yashige H; Tsuji H; Inazawa J; Yokota S; Nishigaki H; Okuda T; Horiike S; Taniwaki M; Misawa S; Abe T
Gan To Kagaku Ryoho; 1987 Jun; 14(6 Pt 1):1917-20. PubMed ID: 3109330
[TBL] [Abstract][Full Text] [Related]
18. [Clinical evaluation of MMC-mc-chemoembolization therapy and its combination with UFT in hepatocellular carcinoma].
Ohmura K; Suzuki M; Takao ; Matsuo SK; Ohtsuka Y
Gan To Kagaku Ryoho; 1987 Feb; 14(2):523-6. PubMed ID: 3028278
[TBL] [Abstract][Full Text] [Related]
19. [Complete response of unresectable gastric cancer (Borrmann's type III) treated with combination chemotherapy of UFT and mitomycin--a case report].
Iwase H; Morise K; Suga S; Ina K; Masuda T; Ohashi M
Gan No Rinsho; 1987 Jun; 33(6):729-35. PubMed ID: 3110461
[TBL] [Abstract][Full Text] [Related]
20. Hepatic arterial infusion combined with oral UFT/UZEL systemic chemotherapy for unresectable liver metastasis of colorectal cancer.
Tsutsumi S; Yamaguchi S; Tsuboi K; Fukasawa T; Tabe Y; Asao T; Kuwano H
Hepatogastroenterology; 2008; 55(85):1419-22. PubMed ID: 18795703
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
